Fundraising Fox
🦊/Companies
Sign in

Laekna Therapeutics

6 known investors

Find your way into Laekna Therapeutics

Develops innovative therapies for cancer and liver diseases.

Investors · 6

HB VenturesVienna · $1M – $10M
OrbiMedNew York · $1M – $75M
Infinity Capitalreported · 2 sourcesAtlanta

Also in the syndicate · 3

CS CapitalleadWorldstarYanchuang Capital

Funding

SEC filings, press & company announcements

$61M disclosed across 1 round · 2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Laekna raises $61m to accelerate product developmentpharmaceutical-technology.com · May 2022Biotech startup Laekna snags $61m and 20 more deal updates worth $298mdealstreetasia.com · May 2022Laekna Therapeutics Raises $61 Million in Series D financing - BioSpacebiospace.com · May 2022Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 | Journal of Clinical Oncologyascopubs.org

Frequently asked questions

What does Laekna Therapeutics do?
Develops innovative therapies for cancer and liver diseases.
Who are Laekna Therapeutics's investors?
Laekna Therapeutics's investors include HB Ventures, OrbiMed, Infinity Capital.
How much funding has Laekna Therapeutics raised?
Laekna Therapeutics has disclosed $61M raised across 1 round.